V

Vista Pharmaceuticals Limited

VISTAPH
Market snapshot · 2026-08-11 11:18 UTC

6.72

₹-0.23 (-3.31%)

MARKET CAP

₹41.36 Cr

STOCK P/E

52W HIGH

₹11.17

52W LOW

₹5.71

BOOK VALUE

₹7.24

EPS

₹-1.96

ROE

SECTOR

Health Care

DEBT/EQUITY

19.05

VOLUME

12,849

P/B RATIO

0.93x

PEG RATIO

Sector

Health Care

Themes

Pharmaceuticals
₹10.97₹9.79₹8.61₹7.42₹6.24VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/S
Strongly Undervalued

5Y Average

7.39

Current

4.79

Overvalued

8.66

Undervalued

5.93

P/B
Strongly Undervalued

5Y Average

1.25

Current

0.93

Overvalued

1.43

Undervalued

1.06

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.00 CrMar 2026

Latest net profit

₹-6.00 CrMar 2026

Latest EPS

₹-0.91Mar 2026

Free cash flow

₹-5.00 CrMar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-260.0%-195.0%-130.0%-65.0%0.0%-6.00 Cr-3.00 Cr0.00 Cr3.00 Cr6.00 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr0.75 Cr1.50 Cr2.25 Cr3.00 Cr₹-1₹-1₹-1₹-0₹-0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherOtheradjustmentsNet Profit-12 Cr-9.00 Cr-6.00 Cr-3.00 Cr0.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2025Sep 2025Mar 2026-25 Cr0.00 Cr25 Cr50 Cr75 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹0 Cr

-100.0%

Net Profit

₹-6 Cr

-292.0%

EBITDA

₹-7 Cr

-947.2%

EPS

₹-0.91

-15.2%
MetricDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales32120
Expenses43567
Operating Profit-1-1-4-3-7
OPM %-33.94%-84.73%-248.66%-132.03%
Other Income00000
Interest00001
Depreciation00000
Profit before tax-1-1-4-3-8
Tax %-40.82%12.82%28.53%29.3%24.53%
Net Profit-1-1-3-2-6
EPS in Rs-0.79-0.22-0.42-0.41-0.91

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Loading shareholding pattern...